SEI Investments’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.02M Buy
196,165
+78,896
+67% +$1.18M ﹤0.01% 1734
2026
Q2
$1.53M Sell
117,269
-95,440
-45% -$1.09M ﹤0.01% 2092
2026
Q1
$2.42M Sell
212,709
-9,419
-4% -$102K ﹤0.01% 1919
2025
Q4
$2.85M Buy
+222,128
New +$2.74M ﹤0.01% 1671
2025
Q2
– Sell
-31,430
Closed -$295K – 2792
2025
Q1
$295K Buy
+31,430
New +$330K ﹤0.01% 2346
2024
Q1
– Sell
-72,422
Closed -$568K – 2623
2023
Q4
$568K Buy
+72,422
New +$502K ﹤0.01% 2059
2022
Q1
– Sell
-9,263
Closed -$255K – 2573
2021
Q4
$255K Hold
9,263
– – ﹤0.01% 2389
2021
Q3
$240K Sell
9,263
-35,395
-79% -$946K ﹤0.01% 2393
2021
Q2
$1.21M Buy
+44,658
New +$1.09M ﹤0.01% 1732
2020
Q3
– Sell
-35,275
Closed -$359K – 2403
2020
Q2
$359K Sell
35,275
-15,956
-31% -$164K ﹤0.01% 2001
2020
Q1
$534K Hold
51,231
– – ﹤0.01% 1718
2019
Q4
$820K Hold
51,231
– – ﹤0.01% 1717
2019
Q3
$944K Buy
51,231
+20,440
+66% +$400K ﹤0.01% 1626
2019
Q2
$606K Hold
30,791
– – ﹤0.01% 1787
2019
Q1
$704K Sell
30,791
-9,469
-24% -$206K ﹤0.01% 1716
2018
Q4
$875K Hold
40,260
– – ﹤0.01% 1565
2018
Q3
$875K Sell
40,260
-8,430
-17% -$187K ﹤0.01% 1500
2018
Q2
$1.08M Buy
+48,690
New +$995K ﹤0.01% 1550
2018
Q1
– Sell
-70
Closed -$1K – 3453
2017
Q4
$1K Buy
+70
New +$1.19K ﹤0.01% 3176
2017
Q3
– Sell
-49
Closed -$1K – 3190
2017
Q2
$1K Hold
49
– – ﹤0.01% 2910
2017
Q1
$1K Sell
49
-136
-74% -$2.27K ﹤0.01% 2768
2016
Q4
$3K Buy
185
+136
+278% +$2.27K ﹤0.01% 2650
2016
Q3
$1K Hold
49
– – ﹤0.01% 2710
2016
Q2
$1K Hold
49
– – ﹤0.01% 2525
2016
Q1
$1K Buy
+49
New +$541 ﹤0.01% 2415
2015
Q4
– Sell
-50,613
Closed -$668K – 2521
2015
Q3
$668K Buy
50,613
+50,123
+10,229% +$757K 0.01% 1182
2015
Q2
$8K Buy
490
+72
+17% +$1.2K ﹤0.01% 1941
2015
Q1
$7K Buy
418
+134
+47% +$2.49K ﹤0.01% 1961
2014
Q4
$4K Buy
+284
New +$4.81K ﹤0.01% 1981

Other funds holding ANGO

SEI Investments's ANGO Position: Q3 2026 in Review

SEI Investments increased its AngioDynamics (ANGO) stake by 67% in Q3 2026, buying an estimated $1.18M and bringing the position to 196,165 shares worth $3.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1734.

SEI Investments first reported a position in ANGO in Q4 2014 and has held it in 29 quarters since. 172 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.

  • SEI Investments held 196,165 shares of AngioDynamics worth $3.02M as of Q3 2026.
  • SEI Investments bought 78,896 AngioDynamics shares in Q3 2026, an estimated $1.18M.
  • AngioDynamics made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #1734 holding.
  • SEI Investments first reported a position in AngioDynamics in Q4 2014 and has held it in 29 quarters since.
  • 172 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.